At JPM, Eli Lilly’s CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected
MedCity News
JANUARY 14, 2025
The post At JPM, Eli Lillys CEO Explains Why Mounjaro, Zepbound Sales Were Lower Than Expected appeared first on MedCity News. Morgan Healthcare Conference, Lilly CEO David Ricks explained why the company revised downward its projections for fourth quarter 2024 revenue.
Let's personalize your content